Form 4 Filing for Amneal Pharmaceuticals, Inc.

2026-05-12SEC Filing 4 (0001628280-26-034106)

Deborah M. Autor, a director at Amneal Pharmaceuticals, Inc. (AMRX), reported a sale of 34,819 shares of Class A Common Stock on May 11, 2026. The sale was executed at a weighted average price of $12.94 per share, with individual transactions ranging from $12.75 to $13.27. Following these transactions, Ms. Autor directly holds 93,660 shares of the company's stock. The filing indicates that full details regarding the specific prices and number of shares sold at each price within the reported range will be provided to the SEC upon request.